Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease
Bioorganic Chemistry(2022)
摘要
•JNK3 has become a promising drug target for Alzheimer’s disease.•Recent progress has been made in treating Alzheimer’s disease with JNK3 inhibitors.•This review is focused on small molecules targeting JNK3 and their mechanism of action.•The tight banding with hydrophobic picket Ⅰ is essential to improve JNK3 isoform-selectivity.•The formation of hydrogen bonds with Met149 is the key to improving inhibitory activity.
更多查看译文
关键词
JNK3 inhibitors,Alzheimer’s disease,Aβ,Tau,Inflammation,Structure-activity relationship
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要